OU Health has been awarded a $5.3 million federal grant to continue a partnership with OMRF and the VA on research into the biology of aging and the role it plays in the onset of diseases like cancer and diabetes.
OMRF scientists have identified a compound that could give birth to therapies for a host of eye diseases.
Heart Disease is the number one cause of death in diabetic patients.
The findings could potentially lead to new drugs to help weight loss or combat obesity and associated metabolic disorders.
The findings could lead to new treatments to limit the damaging cardiac effects of diabetes.
A husband-wife team at OMRF studies how diabetes affects the heart.